Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function
Foster Y, Grant M, Thomas S, Cameron B, Raiff D, Corbet K, Ferreri C, Horwitz M. Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function. Blood 2018, 132: 4594. DOI: 10.1182/blood-2018-99-113189.Peer-Reviewed Original ResearchLong-term renal functionAcute kidney failureAcute kidney injuryChronic kidney diseaseRenal functionChronic GVHDNephrotoxic drugsHuman herpes virus-6 (HHV-6) reactivationAllogeneic hematopoietic cell transplantEnd-stage renal diseaseAlternative donor graftsHHV-6 viremiaUnadjusted median survivalRetrospective cohort studyHematopoietic cell transplantTransplant-related factorsGlomerular filtration rateSerum creatinine valuesMultivariate logistic regressionCKD-EPI equationUmbilical cord bloodManual chart reviewAcute GVHDEGFR declineLower eGFRsHSCT‐GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature
Grant M, Horwitz M. HSCT‐GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature. Case Reports In Transplantation 2018, 2018: 2376483. PMID: 29721346, PMCID: PMC5867646, DOI: 10.1155/2018/2376483.Peer-Reviewed Original ResearchConditioning regimenWatermelon stomachManifestation of chronic graft-versus-host diseaseChronic graft-versus-host diseaseBusulfan-containing conditioning regimenGraft-versus-host diseaseGastric antral vascular ectasiaNonvariceal upper GI bleedingBone marrow transplantationAntral vascular ectasiaChronic renal failureUpper gastrointestinal bleedingUpper GI bleedingChronic GVHDHost diseaseMarrow transplantationGI bleedingRenal failureSystemic sclerosisGastrointestinal bleedingVascular ectasiaCase reportEctatic vesselsGastric antrumPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply